Approved as
amended by FDA in its revised supporting statement with appropriate
changes to the burden accounting.
Inventory as of this Action
Requested
Previously Approved
01/31/2011
36 Months From Approved
01/31/2008
43,499
0
38,514
200,839
0
177,165
0
0
0
Sponsors of Investigational New Drug
Applications are required, under the Food and Drug Administration
Modernization Act, to submit information about clinical trials for
serious or life-threatening diseases to a publicly-accessible
clinical trials data bank developed by the National Library of
Medicine.
US Code:
42
USC 1395y Name of Law: Exclusions from Coverage and Medicare as
Secondary Payer
PL:
Pub.L. 105 - 115 113 Name of Law: FDAMA
We believe the previous burden
estimate of 177,165 hours per year underestimated the burden. The
new estimate of 196,668 hours per year more accurately reflects the
burden. The addition of CMS's estimated burden hours has increased
the total.
$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Jonnalynn Capezzuto
3018274659
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.